170 related articles for article (PubMed ID: 26483230)
1. [Efficacy of infliximab in the treatment of Crohn's disease in children].
Teng X; Xu LF; Sun M; Guo J
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Oct; 17(10):1088-92. PubMed ID: 26483230
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of infliximab in treatment of pediatric Crohn's disease in China].
Luo Y; Yu J; Zhao H; Peng K; Lou J; Ma M; Chen J
Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):688-92. PubMed ID: 25476432
[TBL] [Abstract][Full Text] [Related]
3. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the infliximab therapy of severe form of pediatric Crohn's disease in Poland: Retrospective, multicenter studies.
Iwańczak BM; Ryżko J; Jankowski P; Sładek M; Wasilewska A; Szczepanik M; Sienkiewicz E; Szaflarska-Popławska A; Więcek S; Czaja-Bulsa G; Korczowski B; Maślana J; Iwańczak F; Kacperska M
Adv Clin Exp Med; 2017; 26(1):51-56. PubMed ID: 28397432
[TBL] [Abstract][Full Text] [Related]
5. The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn's disease.
Kierkus J; Dadalski M; Szymanska E; Oracz G; Wegner A; Gorczewska M; Szymanska S; Woynarowski M; Ryzko J
Eur J Gastroenterol Hepatol; 2012 May; 24(5):495-500. PubMed ID: 22387887
[TBL] [Abstract][Full Text] [Related]
6. [Platelet count predicts therapeutic response of infliximab for active Crohn's disease].
Shen H; Xu C; Chen C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):81-5. PubMed ID: 27045246
[TBL] [Abstract][Full Text] [Related]
7. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.
Kugathasan S; Werlin SL; Martinez A; Rivera MT; Heikenen JB; Binion DG
Am J Gastroenterol; 2000 Nov; 95(11):3189-94. PubMed ID: 11095340
[TBL] [Abstract][Full Text] [Related]
8. Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients.
Olbjørn C; Nakstad B; Småstuen MC; Thiis-Evensen E; Vatn MH; Perminow G
Scand J Gastroenterol; 2014 Dec; 49(12):1425-31. PubMed ID: 25310799
[TBL] [Abstract][Full Text] [Related]
9. Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease.
Szabó D; Kökönyei G; Arató A; Dezsőfi A; Molnár K; Müller KE; Lakatos PL; Papp M; Lovász BD; Golovics PA; Cseh A; Veres G
J Crohns Colitis; 2014 Aug; 8(8):747-55. PubMed ID: 24434181
[TBL] [Abstract][Full Text] [Related]
10. Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease.
Baldassano R; Braegger CP; Escher JC; DeWoody K; Hendricks DF; Keenan GF; Winter HS
Am J Gastroenterol; 2003 Apr; 98(4):833-8. PubMed ID: 12738464
[TBL] [Abstract][Full Text] [Related]
11. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
[TBL] [Abstract][Full Text] [Related]
12. [X-linked inhibitor of apoptosis deficiency manifested as Crohn's disease: a case report and literature review].
Xu LJ; Luo YY; Yu JD; Lou JG; Fang YH; Chen J
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):43-47. PubMed ID: 29342997
[No Abstract] [Full Text] [Related]
13. Use of infliximab in the treatment of Crohn's disease in children and adolescents.
Hyams JS; Markowitz J; Wyllie R
J Pediatr; 2000 Aug; 137(2):192-6. PubMed ID: 10931411
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 10 cases of pediatric Crohn's disease].
Tang S; Wu XP; You JY
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Aug; 16(8):824-8. PubMed ID: 25140776
[TBL] [Abstract][Full Text] [Related]
15. Intestinal ultrasound score predicts therapeutic outcomes of infliximab in pediatric patients with Crohn's disease.
Wang L; Zhang Y; Wu H; Tang Z; Wang Y; Huang Y
Scand J Gastroenterol; 2024; 59(2):156-163. PubMed ID: 37905747
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of infliximab in the treatment of pediatirc Crohn's disease].
Xu X; Xiao Y; Yu Y; Li J; Huang YQ; Cao W; Hu H; Zhang T; Xu CD; Wang XQ
Zhonghua Er Ke Za Zhi; 2021 Jul; 59(7):557-562. PubMed ID: 34405637
[No Abstract] [Full Text] [Related]
17. [Infliximab therapy in children and adolescents with refractory Crohn's disease in the Netherlands; experience with 23 patients].
de Ridder L; Escher JC; Taminiau JA
Ned Tijdschr Geneeskd; 2002 Oct; 146(40):1879-83. PubMed ID: 12395595
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.
Fasanmade AA; Adedokun OJ; Blank M; Zhou H; Davis HM
Clin Ther; 2011 Jul; 33(7):946-64. PubMed ID: 21741088
[TBL] [Abstract][Full Text] [Related]
19. Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease.
Sinitsky DM; Lemberg DA; Leach ST; Bohane TD; Jackson R; Day AS
J Gastroenterol Hepatol; 2010 Apr; 25(4):810-6. PubMed ID: 20492339
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Crohn's disease treated with infliximab and 4 years of follow up.
Yoong C; Schofield C; Rodins K; Faulkner C
Australas J Dermatol; 2014 Aug; 55(3):e40-3. PubMed ID: 23772972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
